Skip to content
healthcare.dev

Rasagiline

NDC 64980-712, Rasagiline mesylate, tablet, from Rising Pharma Holdings, Inc..

Product NDC
64980-712
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218163
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-712 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE1 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
64980-712-306498007123030 TABLET in 1 BOTTLE (64980-712-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7d9eac3f-7441-45cf-a603-ea18c116e2c0
  • NADAC price for package 64980071230

    GET /v1/drugs/nadac/64980071230

Use it

Look up 64980-712 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-712 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-712. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.